SEC Form 4 · accession 0001874041-26-000007
Cytek Biosciences, Inc. · CTKB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ming Yan
Officer — CHIEF TECHNOLOGY OFFICER · Director
Period of report
Jun 12, 2026
Accepted (ET)
Jun 16, 2026 · 4:59 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001831915
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 12, 2026 | G | 135,892 | $0.00 | D | 4,796,688 | D |
Table II — derivative securities
No Table II lines on this filing.